Skip to main content
. Author manuscript; available in PMC: 2013 Apr 15.
Published in final edited form as: Arch Biochem Biophys. 2012 Mar 5;520(2):108–116. doi: 10.1016/j.abb.2012.02.018

Table 2.

Equilibrium and kinetic parameters for the binding reaction of WT and R212A CYP3A4 with ritonavir and its analogs.

DAR
DTMCR
Ritonavir
WT R212A WT R212A WT R212A
Ksa, μM 0.5 ± 0.1 2.2 ± 0.2 3.6 ± 0.2 6.6 ± 0.4 0.05 ± 0.01b 0.064 ± 0.008
Kdc, μM d 0.16 ± 0.04
kfaste, s−1 0.29 ± 0.03 0.15 ± 0.02 1.0 ± 0.1 0.70 ± 0.03 1.4 ± 0.2 1.1 ± 0.2
kslowf, s−1 0.07 ± 0.01 0.030 ± 0.002 0.13 ± 0.02 0.07 ± 0.01 0.19 ± 0.03 0.22 ± 0.02
a

Spectroscopic dissociation constant.

b

Determined previously [7].

c

Kinetic dissociation constants.

d

Kd cannot be determined because of non-hyperbolic binding kinetics.

e,f

Rate constants in the fast and slow phases, respectively, determined at a maximal ligand concentration (18 μM).